Business Standard

Cipla launches etanercept biosimilar

The drug, used to treat rheumatic disorders, is manufactured by China's Shanghai CP Guojian Pharmaceutical Co and would be sold by Cipla in India through a partnership

Reuters Mumbai

Drugmaker Cipla Ltd said on Wednesday it has launched etanercept biosimilar in India under the brand name Etacept.

The drug, used to treat rheumatic disorders, is manufactured by China's Shanghai CP Guojian Pharmaceutical Co and would be sold by Cipla in India through a partnership, it said in a statement.

 

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 17 2013 | 4:54 PM IST

Explore News